Crossref journal-article
Wiley
Metal-Based Drugs (311)
Abstract

The complex [Pt2Cl2(Spym)4], where Spym = 2‐mercaptopyrimidine, was synthesized and analyzed spectroscopically. The presence in the  195Pt NMR spectrum, of only one signal for the Pt(III) indicates the symmetrical arrangement of the ligands and the identical setting of N, S and Cl atoms, PtS2ClN2, for the two Pt atoms being different to other compounds described in the literature. The interaction of this complex with DNA was studied by several techniques, including circular dichroism, melting temperature determination, electron microscopy (EM) and atomic force microscopy (TMAFM). Preliminary results show a high activity against HL‐60 and HeLa tumour lines for the Pt‐2‐mercaptopyrimidine complex in comparison with cisplatin activity. Higher values for IC50 were obtained, while the values of LD50 were lower than those for cisplatin.

Bibliography

Cervantes, G., Prieto, M. J., & Moreno, V. (1997). Antitumour Activity of a pt(III) Derivative of 2‐Mercaptopyrimidine. Metal-Based Drugs, 4(1), 9–18. Portico.

Authors 3
  1. G. Cervantes (first)
  2. M. J. Prieto (additional)
  3. V. Moreno (additional)
References 0 Referenced 41

None

Dates
Type When
Created 18 years, 5 months ago (March 14, 2007, 8:33 a.m.)
Deposited 1 year ago (Aug. 8, 2024, 11:11 a.m.)
Indexed 1 year ago (Aug. 8, 2024, 12:10 p.m.)
Issued 28 years, 8 months ago (Jan. 1, 1997)
Published 28 years, 8 months ago (Jan. 1, 1997)
Published Online 28 years, 7 months ago (Jan. 21, 1997)
Published Print 28 years, 8 months ago (Jan. 1, 1997)
Funders 0

None

@article{Cervantes_1997, title={Antitumour Activity of a pt(III) Derivative of 2‐Mercaptopyrimidine}, volume={4}, ISSN={1687-5486}, url={http://dx.doi.org/10.1155/mbd.1997.9}, DOI={10.1155/mbd.1997.9}, number={1}, journal={Metal-Based Drugs}, publisher={Wiley}, author={Cervantes, G. and Prieto, M. J. and Moreno, V.}, year={1997}, month=jan, pages={9–18} }